TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
Transarterial Embolization and Microwave Ablation Combination Therapy in Early-stage Hepatocellular Carcinoma: A Randomized Trial
Sponsor: Wake Forest University Health Sciences
Terminated
Lack of funding
Other terminated trials from Wake Forest University Health Sciences
- Osteoarthritis · Oct 2025
- Painful Diabetic Neuropathy · Oct 2025
- Ventral Hernia · Phase NA · Jun 2025
- Ventral Hernia · Phase NA · Mar 2025
- Shoulder Injury · Phase NA · Oct 2024
See all terminations from Wake Forest University Health Sciences
Other Hepatocellular Carcinoma trials with similar outcome
Listed as NCT02704130, this NA trial focuses on Hepatocellular Carcinoma and Hepatoma and remains terminated or withdrawn. Sponsored by Wake Forest University Health Sciences, it has been updated 11 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2022 — Jul 2024 [monthly]
Terminated NA
-
Apr 2022 — May 2022 [monthly]
Terminated NA
-
Jan 2021 — Apr 2022 [monthly]
Terminated NA
▶ Show 6 earlier versions
-
May 2019 — Jan 2021 [monthly]
Terminated NA
-
Aug 2018 — May 2019 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .